Prevention of end-stage renal disease due to type 2 diabetes.
Hostetter
T H
TH
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000517:prevention & control*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents